The serum prostate-specific antigen level three months after radiotherapy for prostate cancer: an early indicator of response to treatment
- 28 February 1994
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 30 (2) , 121-127
- https://doi.org/10.1016/0167-8140(94)90040-x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Is Prostate Specific Antigen of Clinical Importance in Evaluating Outcome after Radical ProstatectomyJournal of Urology, 1993
- Serum prostate-specific antigen in monitoring the response of carcinoma of the prostate to radiation therapyRadiotherapy and Oncology, 1992
- Prostate Specific Antigen in the Management of Patients with Localized Adenocarcinoma of the Prostate Treated with Primary Radiation TherapyJournal of Urology, 1991
- Prostate Specific Antigen after Irradiation for Prostatic CarcinomaJournal of Urology, 1990
- Prostate Specific Antigen and Local Recurrence after Radical ProstatectomyJournal of Urology, 1990
- Prostatc specific antigen as an indicator of response to radiotherapy in prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Clinical use of Prostate Specific Antigen in Patients with Prostate CancerJournal of Urology, 1989
- Identification of Residual Cancer in the Prostate Following Radiation Therapy: Role of Transrectal Ultrasound Guided Biopsy and Prostate Specific AntigenJournal of Urology, 1989
- Prostate Specific Antigen in the Preoperative and Postoperative Evaluation of Localized Prostatic Cancer Treated with Radical ProstatectomyJournal of Urology, 1988
- Histologic grading study of prostate adenocarcinoma: The development of a new system and comparison with other methods—A preliminary studyCancer, 1982